Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pacific Biosciences (NQ: PACB )

1.695 +0.105 (+6.60%)
Streaming Delayed Price Updated: 2:05 PM EDT, Sep 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,942,169
Open 1.670
Bid (Size) 1.690 (104)
Ask (Size) 1.700 (162)
Prev. Close 1.590
Today's Range 1.650 - 1.741
52wk Range 1.160 - 10.65
Shares Outstanding 247,079,374
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
A Biotech Breakout Will Be Led By Small Caps
It’s hard to focus on biotech stocks right now because there are many distractions. The Fed and the rate cuts, AI and semiconductor stocks and geopolitical turmoil seemingly worse than ever. 
Via Talk Markets
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Interest Rates
Quanex Building Products Posts Better-Than-Expected Results, Joins Zumiez, Guidewire Software, Smartsheet And Other Big Stocks Moving Higher On Friday
Via Benzinga

Performance

YTD
-82.33%
-82.33%
1 Month
+5.94%
+5.94%
3 Month
+25.09%
+25.09%
6 Month
-54.44%
-54.44%
1 Year
-79.40%
-79.40%

More News

Read More
What 5 Analyst Ratings Have To Say About Pacific Biosciences
Via Benzinga
Applied Materials, Amcor, RLX Technology And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
Analyst Scoreboard: 5 Ratings For Pacific Biosciences
Via Benzinga
Peering Into Pacific Biosciences's Recent Short Interest
Via Benzinga
Form Bio and PacBio Announce Collaboration to Launch New Resources Set to Transform AAV Design and Analysis Best Practices
Via ACCESSWIRE
How Is The Market Feeling About Pacific Biosciences?
Via Benzinga
PACB Stock Earnings: Pacific Biosciences Beats EPS, Misses Revenue for Q2 2024
Via InvestorPlace
PACB Investors Have Opportunity to Join Pacific Biosciences of California, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Dow Rallies To All-Time Highs, Small Caps Outperform Tech, Gold Hits Records On Heightened September Rate Cut Bets: What's Driving Markets Tuesday?
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Expert Outlook: Pacific Biosciences Through The Eyes Of 10 Analysts
Via Benzinga
Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
UnitedHealth Posts Better-Than-Expected Earnings, Joins AngioDynamics, Bank of America And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Strategic Buy Lights Up This Biotech Stock: Time to Invest?
Via MarketBeat
Bank of New York Mellon Posts Upbeat Earnings, Joins Archer Aviation, Rivian Automotive And Other Big Stocks Moving Higher On Friday
Via Benzinga
Methode Electronics Posts Strong Sales, Joins QuantumScape, Ribbon Communications And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Jefferies Says Buy These 3 Stocks for More Than Double-Digit Returns
Via InvestorPlace
Critical Insights From Pacific Biosciences Analyst Ratings: What You Need To Know
Via Benzinga
Cathie Wood's Ark Innovation ETF Sees Sharp Decline Among Top Holdings — Here Are 10-Largest Losers Within ARKF
Via Benzinga
Topics ETFs
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Sony Group Posts Upbeat Earnings, Joins GameStop, Paysafe And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
PACB Stock Earnings: Pacific Biosciences Beats EPS, Misses Revenue for Q1 2024
Via InvestorPlace
Why Perficient Shares Are Trading Higher By Around 53%? Here Are 20 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.